Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Esther Cho
18 Aug 2026
Chief Legal Officer
Sell
4,485
$10.29
$46.15K
Lorena Raquel Lerner
18 Aug 2026
Chief Scientific Officer
Sell
3,568
$10.29
$36.71K
Annita Tanini
18 Aug 2026
Corp. Controller & VP, Finance
Sell
1,224
$10.29
$12.59K
Jasbir Seehra
19 Feb 2026
Chief Executive Officer
Sell
7,015
$16.17
$113.43K
Keith Regnante
18 Feb 2026
Chief Financial Officer
Sell
4,739
$16.35
$77.48K
Esther Cho
18 Feb 2026
SVP, General Counsel
Sell
4,745
$16.35
$77.58K
Lorena Raquel Lerner
18 Feb 2026
Chief Science Officer
Sell
3,873
$16.35
$63.32K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 868,776
History held since 8 Apr 2020